Henk G. van der Poel
Department Urology
Netherlands Cancer Institute
Amsterdam
Netherlands
Name/email consistency: high
- Role of extent of fascia preservation and erectile function after robot-assisted laparoscopic prostatectomy. van der Poel, H.G., de Blok, W. Urology (2009)
- Words of wisdom. Re: Development of a second-generation antiandrogen for treatment of advanced prostate cancer. Tran C, Ouk S, Clegg NJ, et al. van der Poel, H.G. Eur. Urol. (2009)
- Preservation of lateral prostatic fascia is associated with urine continence after robotic-assisted prostatectomy. van der Poel, H.G., de Blok, W., Joshi, N., van Muilekom, E. Eur. Urol. (2009)
- Peroperative transrectal ultrasonography-guided bladder neck dissection eases the learning of robot-assisted laparoscopic prostatectomy. van der Poel, H.G., de Blok, W., Bex, A., Meinhardt, W., Horenblas, S. BJU Int. (2008)
- Sequential treatment for recurrent localized prostate cancer. Van Der Poel, H.G., Moonen, L., Horenblas, S. J. Surg. Oncol (2008)
- Perineal salvage prostatectomy for radiation resistant prostate cancer. van der Poel, H.G., Beetsma, D.B., van Boven, H., Horenblas, S. Eur. Urol. (2007)
- Molecular markers in the diagnosis of prostate cancer. van der Poel, H.G. Crit. Rev. Oncol. Hematol. (2007)
- Serum hemoglobin levels predict response to strontium-89 and rhenium-186-HEDP radionuclide treatment for painful osseous metastases in prostate cancer. van der Poel, H.G., Antonini, N., Hoefnagel, C.A., Horenblas, S., Valdes Olmos, R.A. Urol. Int. (2006)
- Androgen receptor and TGFbeta1/Smad signaling are mutually inhibitory in prostate cancer. van der Poel, H.G. Eur. Urol. (2005)
- Smart drugs in prostate cancer. van der Poel, H.G. Eur. Urol. (2004)